The aim of this project is to reduce the resorption rates in fat grafting procedures with our novel injectable gel material. The combination of the gel and adipose tissue-derived stem
cells plays the key supporting role in enhanced fat graft survival. The goal of this project is to establish a preclinical data set demonstrating the improved fat graft survival via increased cell viability, reliability and safety of our novel material, strengthening valorisation development for clinical establishment of this product.
The project outcome, including acquiring in vitro and in vivo data as well as regulatory advice will allow us to further establish the business case, towards a good license opportunity or a spin-off trajectory.